Topic Archives: Sanofi (SNY)

Such A Pleasant Stay

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. All of his past articles and most recent comments are on his Stock Gumshoe page.] “Thanks to you I’m much obliged Such a […]

A Non-Statin Pill That Really Lowers Cholesterol, Blood Pressure and Inflammation without Side Effects Would be a Good Investment, Right?

[Ed. Note: Dr. KSS writes about medical topics and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his thoughts and words are his own. Enjoy!] Any discussion of cholesterol immediately turns Brobdingnagian, such are the extremes in question. Statins, which lower LDL cholesterol, are bombastically the best-selling drugs of all […]

Hepatitis with a C

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. His words and opinions are his own.] In A History of New York, Washington Irving opens chapter VIII thus: ”In which the author and reader…fall into a very grave and instructive discourse.” This may prove to be a more unleavened column than […]


  • Avatar

    $TSRO $GILD $SNY "Buyout Buzz: Sanofi, Gilead rumors keep the fire burning under a boiling Tesaro buyout story" At...

  • Avatar

    this was a $2.00 stock at the time of the original post above (9 months ago). WOW Flexion Therapeutics - $FLXN +40% j...

  • Avatar

    Pre-market actions, 1/6, per IBD at 8:45am In Motion: Amgen, Regeneron, Ionis, Verizon Premarket action was a mixe...

  • Avatar

    Sanofi (SNY) and Google teaming up for new start up Onduo targeting diabetes treatments.

  • Avatar

    Long $RLYP Short article, and nice summation of current position. RLYP has applied for Eu...

  • Avatar

    I think Sanofi ($SNY) was meant....

  • Avatar

    Sanofi (SNY) on the hunt for rare disease acquisitions.

  • Avatar

    Doc KSS, First and foremost, glad you are on the mend. I was wondering if you could kindly comment on the effica...

  • Travis Johnson, Stock Gumshoe

    Could be, the hints were all over the map on this since he's teasing RNAi generally and hinting at lots of studies done ...

  • This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

    Connect with Travis

    website designed by Gravity Switch